In TCGA database, joint effects analysis of CYP2C8,CYP2C9, and CYP2C19 showed that the risk of death from HCC was lower for groups C and D than for group A (adjusted P = 0.012 and P = 0.008, respectively). This evidence concerns the gene CYP2C19 and hepatocellular carcinoma.